SureTrader Advertisement Advertisement Advertisement
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, BooDog, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 10/10/2015 1:33:00 AM - Followers: 651 - Board type: Free - Posts Today: 4

Cellceutix Corporation (CTIX)
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
CIK:  0001355250
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.


The above link is kept updated.

Ongoing Human Trials:
Product Pipeline:

Recent News and Press Releases:

Seeking Alpha focus articles on CTIX:

A randomized, double-blind study comparing single-dose and short-course brilacidin to daptomycin in the treatment of acute bacterial skin & skin structure infections (ABSSSI)

Synthetic novel host defense protein mimetics for the treatment of Gram-negative bacterial infections

SEC Filings:

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f

Share Structure:  See SEC filing link above for current share structure

Cellceutix IP - Patent Filings:

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
External Links: USPTO, USPTO Assignment, Espacenet

Investor Relations:

Following is a WEEKLY chart:


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
CTIX News: Special Profile Coming and 4 Analyst Reports 07/21/2015 07:00:00 AM
CTIX News: Undervalued and Underexposed NYSE-MKT Stock to be Profiled by Large Media Group and four brief reports 06/15/2015 07:00:00 AM
CTIX News: Special Profile & Four Companies Where Investors are Anticipating Success 06/03/2015 07:00:00 AM
CTIX News: *Special Analyst Alert* and 4 Companies that are Worth a Look 05/13/2015 07:00:00 AM
CTIX News: Quarterly Report (10-q) 05/11/2015 02:03:16 PM
#125074  Sticky Note $CTIX Cellceutix Alerts Shareholders to National Media on CHM_760 10/09/15 10:06:39 AM
#121761  Sticky Note Cellceutix Announces Filing of its Annual Report on TOB 09/14/15 09:28:06 AM
#120460  Sticky Note Cellceutix’s Prurisol: A Potential Blockbuster Psoriasis Treatment TOB 08/28/15 03:20:01 PM
#119441  Sticky Note Cellceutix's Clinical Trial of Anti-Cancer Agent Kevetrin Meeting starbuxsux 08/20/15 03:41:27 PM
#118219  Sticky Note $CTIX - My visit to Cellceutix, the biotech KarinCA 08/14/15 02:19:08 PM
#117003  Sticky Note Cellceutix released efficacy data for Kevetrin, its cancer TOB 08/09/15 03:05:24 PM
#125189   Both fast track and priority review will be sox040713 10/10/15 01:33:00 AM
#125188   Besides the normal criteria for fast track, being thefamilyman 10/10/15 01:19:02 AM
#125187   I'm not giving a definition of anything, I Waverunner1 10/10/15 12:03:57 AM
#125186   Where it is documented? Go to clinical trial site Amatuer17 10/10/15 12:01:22 AM
#125185   Not sure your definition of fast track is Amatuer17 10/09/15 11:56:57 PM
#125184   The request has not been made yet. A Waverunner1 10/09/15 11:48:46 PM
#125183   Potential. It really is amazing. Kevetrin. Eom BooDog 10/09/15 10:39:34 PM
#125182   If there's anything I'm surprised about it's that frrol 10/09/15 10:19:02 PM
#125181   Do you believe the handling of the ctix scottsmith 10/09/15 08:45:41 PM
#125180   Amatuer, we are still on the pinks and BobbyKIrk 10/09/15 08:39:36 PM
#125179   Why not call your friend for the answer. bradfordbros 10/09/15 07:38:47 PM
#125178   I think it is well documented that Kevetrin bradfordbros 10/09/15 07:34:17 PM
#125177   Well said. Great post Blzzy! Jhawker 10/09/15 07:07:31 PM
#125176   Wasn't Dumbo an orphan? tduggan 10/09/15 07:05:54 PM
#125175   I am a shareholder and not CEO - Amatuer17 10/09/15 06:50:37 PM
#125174   Interesting to watch the behavior of guys who BIzzy 10/09/15 06:49:09 PM
#125173   You're hilarious Looping 10/09/15 06:45:13 PM
#125172   Wasn't Dumbo an orphan? brucethepotter 10/09/15 06:40:59 PM
#125171   FINRA short sales of CTIX AlanC 10/09/15 06:40:09 PM
#125169   Alright Amateur, you take the weekend but I'll 58nout 10/09/15 06:24:01 PM
#125168   No they are not guesses. You are absolutely BigKahuna 10/09/15 06:15:37 PM
#125167   All guesses except for UOB - speculative - Amatuer17 10/09/15 06:09:34 PM
#125166   Since some think that CTIX has to come BigKahuna 10/09/15 06:01:24 PM
#125165   Good accurate summary...its also seriously an impressive road faraifarai 10/09/15 05:41:49 PM
#125164   Amateur: your handle speaks volumes. Trials take a faraifarai 10/09/15 05:35:53 PM
#125163   Corrected. Thanks for pointing it out! sox040713 10/09/15 05:20:47 PM
#125162   The pancreatic and renal trial could be paid sox040713 10/09/15 05:19:49 PM
#125161   Amatuer you seem to question everything but provide 58nout 10/09/15 05:18:09 PM
#125160   Sox.. nice summary... I think you meant pancreatic Waverunner1 10/09/15 05:11:49 PM
#125159   How many more years and where is the Amatuer17 10/09/15 05:07:11 PM
#125158   Planned Kevetrin trials: sox040713 10/09/15 05:01:58 PM
#125157   I want to hear Phase 3 trial has Matagordaville 10/09/15 04:59:22 PM
#125156   We can complain and buy at the same noretreat 10/09/15 04:30:27 PM
#125155   was Kevetrin's day, trumpeting some of the progress slcimmuno 10/09/15 04:05:37 PM
#125154   Good news - no news - every penny Amatuer17 10/09/15 04:04:33 PM
#125153   Somebody has one of those highly-sought-after I-told-you-so personalities rule_rationale 10/09/15 04:02:02 PM
#125152   we were at 1.30 only a day or faraifarai 10/09/15 03:50:02 PM
#125151   See I told you once Leo sees how BobbyKIrk 10/09/15 03:34:14 PM
#125150   This p53 slide show is brilliantly simple and frrol 10/09/15 03:24:37 PM
#125149   The comments the other day quoting a poster F1ash 10/09/15 03:22:44 PM
#125148 comes Monentum.....WAIT...OH NO....look... here comes : wild4ctix 10/09/15 03:05:27 PM
#125147   Thank you for sharing this! GO KEVETRIN!!! Ultimate01 10/09/15 03:00:20 PM
#125146   It depends on deal lots of tricky parts akamaii 10/09/15 02:56:04 PM
#125145   Looks like a market sale or 20 k akamaii 10/09/15 02:37:03 PM
#125144   The adult entertainment industry has a lot of Loose Lips 10/09/15 02:30:26 PM
#125143   LOL WellSpring 10/09/15 02:27:16 PM
#125142   Anyone else feeling a breakout close well over ericseb2003 10/09/15 01:59:33 PM
#125140   I hope it didn't cause it to rain centillion 10/09/15 01:43:23 PM
#125139   Thanks F1...that's a great explanation. I appreciate it. wild4ctix 10/09/15 01:41:41 PM
#125138   Indeed, centillion !!! I had a feeling ctix 10/09/15 01:33:55 PM